Yang, C., Xuan, T., Gong, Q., Dai, X., Wang, C., Zhang, R., . . . Li, J. (2024). Efficacy and safety of novel immune checkpoint inhibitor‐based combinations versus chemotherapy as first‐line treatment for patients with extensive‐stage small cell lung cancer. Thoracic Cancer, 15(15), 1246. https://doi.org/10.1111/1759-7714.15310
Chicago-referens (17:e uppl.)Yang, Chuang, et al. "Efficacy and Safety of Novel Immune Checkpoint Inhibitor‐based Combinations Versus Chemotherapy as First‐line Treatment for Patients with Extensive‐stage Small Cell Lung Cancer." Thoracic Cancer 15, no. 15 (2024): 1246. https://doi.org/10.1111/1759-7714.15310.
MLA-referens (9:e uppl.)Yang, Chuang, et al. "Efficacy and Safety of Novel Immune Checkpoint Inhibitor‐based Combinations Versus Chemotherapy as First‐line Treatment for Patients with Extensive‐stage Small Cell Lung Cancer." Thoracic Cancer, vol. 15, no. 15, 2024, p. 1246, https://doi.org/10.1111/1759-7714.15310.
